Amosartan Q (amlodipine/losartan/rosuvastatin)
/ Hanmi
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 08, 2022
An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet
(clinicaltrials.gov)
- P=N/A | N=5400 | Completed | Sponsor: Hanmi Pharmaceutical Company Limited
New trial • Cardiovascular • Dyslipidemia • Hypertension • Metabolic Disorders
1 to 1
Of
1
Go to page
1